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 Abstract:  Alkylglycerol monooxygenase is a tetrahydrobio-
pterin-dependent enzyme that cleaves the  O -alkyl-bond 
of alkylglycerols. It is an exceptionally unstable, hydro-
phobic membrane protein which has never been puri-
fied in active form. Recently, we were able to identify the 
sequence of alkylglycerol monooxygenase. TMEM195, the 
gene coding for alkylglycerol monooxygenase, belongs 
to the fatty acid hydroxylases, a family of integral mem-
brane enzymes which have an 8-histidine motif crucial 
for catalysis. Mutation of each of these residues resulted 
in a complete loss of activity. We now extended the muta-
tional analysis to another 25 residues and identified three 
further residues conserved throughout all members of the 
fatty acid hydroxylases which are essential for alkylglyc-
erol monooxygenase activity. Furthermore, mutation of a 
specific glutamate resulted in an 18-fold decreased affinity 
of the protein to tetrahydrobiopterin, strongly indicating a 
potential important role in cofactor interaction. A gluta-
mate residue in a comparable amino acid surrounding had 
already been shown to be responsible for  tetrahydrobio-
pterin binding in the aromatic amino acid hydroxylases. 
Ab initio modelling of the enzyme yielded a structural 
model for the central part of alkylglycerol monooxyge-
nase where all essential residues identified by mutational 
analysis are in close spatial vicinity, thereby defining the 
potential catalytic site of this enzyme. 
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 Introduction 
 Phenylalanine degradation, neurotransmitter synthesis, 
alkylglycerol cleavage and production of the vessel rela-
xant nitric oxide all share a common feature: the cofac-
tor tetrahydrobiopterin, which is needed for catalysis of 
these processes (for a review, see [ 1 ]). This metabolite 
is structurally related to the vitamins folate and ribo-
flavin, our body however has still conserved the ability 
to synthesise this cofactor from guanosinetriphospate 
in a three-step enzymatic cascade headed by the rate-
limiting enzyme GTP cyclohydrolase I. Tetrahydrobiop-
terin is crucially involved in the activity of eight different 
enzymes, that is, phenylalanine hydroxylase, tyrosine 
hydroxylase, two tryptophan hydroxylases, three nitric 
oxide synthases (neuronal, inducible and endothelial) 
and alkylglycerol monooxygenase (for a review, see [ 1 ]). 
Whereas the former seven enzymes have been exten-
sively studied over the past decades since their first 
description [ 2 – 7 ], alkylglycerol monooxygenase charac-
terisation was hampered because of its high hydropho-
bicity and its extreme lability in standard biochemical 
assays, even though its first description appeared in the 
literature long before most of the other enzymatic reac-
tions [ 8 ]. The only information available up to 2010 was 
based on studies in homogenates from animal tissues 
displaying high activities and gave some insight into the 
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distribution of the enzyme in the animal body, substrate 
specificity and the enzymatic reaction catalysed ([ 9 – 11 ]; 
for a review, see [ 12 ]). 
 Alkylglycerol monooxygenase 
sequence assignment 
 When we took over the project to study alkylglycerol 
monooxygenase in more detail, we were therefore con-
fronted with different challenges. First, a more sensitive 
assay for the enzyme was needed in order to determine 
tiny amounts present in cells or tissues. Second, and most 
crucial, a suitable detergent had to be identified which 
would help the enzyme to keep its catalytic activity even 
under biochemical purification protocols which would 
then allow to enrich the protein over several steps. By this, 
we were hoping to be able to identify the protein sequence 
by means of mass spectrometry. 
 The sensitive assay was developed based on a specifi-
cally synthesised fluorescent alkylglycerol, 1- O -pyrene-
decylglycerol, which was readily accepted by the enzyme 
and cleaved in the corresponding pyrene labelled alde-
hyde, which is converted in cellular and tissue homoge-
nates to pyrenedecanoic acid. Substrate and product were 
separated by HPLC and detected by fluorescence with a 
detection limit of 4 fmol [ 13 ]. 
 The second challenge was more difficult. A whole 
range of detergents were tested but none proved to be satis-
factory for biochemical protocols. Digitonin in concentra-
tion of 2% achieved some solubilisation of the enzyme but 
gel filtration never yielded homogeneous peaks. CHAPS 
(0.5%) could be used to desalt a homogenate containing 
alkylglycerol monooxygenase without losing its activity. 
For more sophisticated enrichment protocols however, 
100% solubilisation as evaluated by appearance of a sym-
metrical peak in gel filtration was needed, which was 
never achieved. We therefore could not follow this stra-
tegy further. Also, alternative strategies such as functional 
library screens as well as total RNA injection screens in 
 Xenopus laevis oocytes did not lead to a sequence for this 
enzyme. 
 We then chose to pursue bioinformatic strategies 
including homology searches to the known tetrahy-
drobiopterin-dependent enzymes to look for a possible 
imprint for cofactor binding as well as browsing motifs 
and expression data of open reading frames with unas-
signed function, and finally we expressed the ten most 
promising candidates in Chinese hamster ovary (CHO) 
cells. By this, we were finally able to identify formerly 
named transmembrane protein 195 (TMEM195) as the 
gene coding for alkylglycerol monooxygenase [ 14 ]. 
 Alkylglycerol monooxygenase 
sequence analysis 
 The sequence of alkylglycerol monooxygenase revealed 
some very striking features, which can at least partly 
explain the difficulties in working with alkylglycerol 
monooxygenase protein. Within the sequence, there is 
a motif found which is denominated as fatty hydroxy-
lases motif (PFAM04116). This motif can be found in very 
few other enzymes in our body, between these there are 
two better described ones, cholesterol-25-hydroxylase 
and fatty acid hydroxylase, as well as some still uncha-
racterised hydroxylases and desaturates. None of these 
members has ever been purified to homogeneity and they 
are thought to be so labile because of an 8-histidine con-
served motif which is thought to bind an iron-oxygen-iron 
cluster that is crucial for catalysis [ 15 ,  16 ]. 
 The alkylglycerol monooxygenase sequence turned 
out to lack detectable sequence homology to any other 
tetrahydrobiopterin-dependent enzyme and therefore 
forms a third and distinct class of tetrahydrobiopterin-
dependent enzymes in addition to the aromatic amino 
acid hydroxylases and the nitric oxide synthases [ 14 ]. 
 Hydrophobicity analysis of the sequence also pro-
vided evidence that this enzyme is highly hydrophobic 
with approximately half of its sequence buried in the mem-
brane bilayer, therefore rendering it difficult to handle it 
without losing the activity. Bacterial expression of such 
a highly hydrophobic protein proved to be unachievable 
in its full length version. We therefore tried to express 
smaller fragments of alkylglycerol monooxygenase, which 
was partly successful; however, no activity could ever be 
obtained from these pieces (see a separate article in this 
issue by Mayer et  al., Expression of full-length human 
alkylglycerol monooxygenase and fragments in  E. coli ). 
 Insights into alkylglycerol mono-
oxygenase catalysis and structure 
 To obtain some insights into the catalytically important res-
idues, we mutated the eight histidines contained in the con-
served motif and expressed the mutant protein in CHO cells. 
All eight proved to be crucial for activity [ 14 ]. We extended 
this analysis to 26 further residues including additional 
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 Figure 1   Schematic topography of alkylglycerol monooxygenase. 
 Ab initio modelling and prediction tools for transmembrane (TM) segments yielded this schematic depiction of how alkylglycerol monooxy-
genase might be folded into the membrane bilayer and where the active site of the enzyme is most likely to be located (highlighted in 
grey). Engineered mutations are shown by various symbols: triangles upward-pointing, eight histidines forming the fatty acid hydroxylases 
motif; triangles downward-pointing, further histidines; circles, glutamates and aspartates; squares, other mutated residues. The hexagon 
depicts the glutamate at position 137, which was shown to be crucial for the interaction with tetrahydrobiopterin. All mutations which led to 
a complete loss in enzymatic activity are shown in white frames and black filling. Reproduced, with permission, from [ 17 ].   ©  The Biochemical 
Society. 
histidines, but also glutamates and aspartates, as well as 
glutamines and some other residues [ 17 ]. In the aromatic 
amino acid hydroxylases binding of tetrahydrobiopterin 
is mediated by a glutamate residue adjacent to one of the 
histidines binding the non-heme iron. When transfecting 
the mutants into CHO cells and assaying the cell homoge-
nates for alkylglycerol monooxygenase acti vity, it became 
evident that there was indeed a glutamate next to one of the 
eight histidines forming the motif that, when mutated into 
alanine, led to an 18-fold increase of the Michaelis Menten 
constant for tetrahydrobiopterin. Furthermore, a ninth his-
tidine was identified which is needed for catalysis [ 17 ]. 
 Owing to the great difficulties in expressing this 
enzyme in bacteria, experimental data for its struc-
ture are not accessible at this time. We therefore tried 
ab initio modelling of residues 37 – 205 of human alkyl-
glycerol monooxygenase using Rosetta membrane. The 
resulting structure together with four membrane pre-
diction tools for the whole sequence led us to a first 
idea of how alkylglycerol monooxygenase is lying in 
the membrane. All residues being proved to be crucial 
for catalysis by site-directed mutagenesis nicely fold 
together yielding a proposed region for the active site of 
the enzyme ( Figure 1 ). 
 Alkylglycerol metabolism and 
physiological implications 
 Alkylglycerol monooxygenase cleaves the ether bond in 
saturated ether lipids: the alkylglycerols. It is the only 
enzyme described which is able to perform this cleavage 
step, which is thought to occur through a tetrahydrobio-
pterin-dependent hydroxylation at the C atom adjacent 
to the ether bond and subsequent rearrangement of the 
resulting hemiacetal into the corresponding aldehyde and 
the glycerol derivative. The metabolic environment this 
ca talytic step belongs to is the ether lipid metabolism, 
which includes biosynthetic routes for all ether bond con-
taining lipids including the plasmalogens and platelet-
activating factor, as well as the degradation of this species. 
Interestingly, many enzymes of these pathways includ-
ing alkyl glycerol monooxygenase have only recently been 
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assigned a sequence or are still orphan enzymes with 
no sequence information available. For a more detailed 
description of the ether lipid metabolism and the related 
enzymes, the reader is referred to a recent review [ 18 ]. 
 So far no physiological and pathophysiological roles 
of alkylglycerol monooxygenase have been reported. One 
way to deduce possible implications at this stage is to look 
at the roles of its substrates: the alkylglycerols in the body. 
These lipids are important in sperm development, they 
are structural components of the brain and a decrease 
in their levels makes the eye more prone to develop cata-
racts [ 19 – 22 ]. Furthermore, platelet-activating factor is 
an inflammatory signal mediator synthesised by cells 
involved in host defence. It plays a role in a diverse range 
of processes in the body including signalling in shock and 
sepsis, mediation of allergy, inflammation and broncho-
constriction (for a review, see [ 23 ]). 
 Influences of alkylglycerol monooxygenase on alkyl-
glycerol levels might therefore be implicated with changes 
in sperm maturation, changes to brain and lens structure, 
and might also terminate the inflammatory signal medi-
ated by platelet-activating factor. Experimental proof of 
this is still not available and is an important quest to be 
pursued in the future. 
 Conclusion 
 Alkylglycerol monooxygenase was first described in 1964 
as a tetrahydrobiopterin-dependent enzyme that can 
cleave the ether bond in alkylglycerols [ 8 ]. After this, it 
took more than four decades to identify the sequence of 
this integral membrane protein [ 14 ] and to obtain some 
insights into its membrane disposition and structural and 
catalytic features [ 17 ]. Current work now focusses on the 
role of alkylglycerol monooxygenase in physiology and 
pathophysiology. 
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